CU23810A3 - Sustancias inmunogénicas que comprenden un adyuvante a base de ácido poliinosínico-ácido policitidílico - Google Patents
Sustancias inmunogénicas que comprenden un adyuvante a base de ácido poliinosínico-ácido policitidílicoInfo
- Publication number
- CU23810A3 CU23810A3 CU20080135A CU20080135A CU23810A3 CU 23810 A3 CU23810 A3 CU 23810A3 CU 20080135 A CU20080135 A CU 20080135A CU 20080135 A CU20080135 A CU 20080135A CU 23810 A3 CU23810 A3 CU 23810A3
- Authority
- CU
- Cuba
- Prior art keywords
- acid
- polytidylic
- understanding
- polyinosinic
- immunogenic substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- AIDS & HIV (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención provee una composición de polinucleótido adyuvante (PICKCa) para provocar una respuesta inmunológica. El polinucleótido adyuvante consiste de ácido polirriboinosínico-polirribocitidílico (PIC), el antibiótico kanamicina e iones calcio. La presente invención provee también una composición inmunogénica que comprende la composición de polinucleótido adyuvante junto con un antígeno viral.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/331,575 US20070166800A1 (en) | 2006-01-13 | 2006-01-13 | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant |
Publications (1)
Publication Number | Publication Date |
---|---|
CU23810A3 true CU23810A3 (es) | 2012-04-15 |
Family
ID=38256597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20080135A CU23810A3 (es) | 2006-01-13 | 2008-07-14 | Sustancias inmunogénicas que comprenden un adyuvante a base de ácido poliinosínico-ácido policitidílico |
Country Status (17)
Country | Link |
---|---|
US (4) | US20070166800A1 (es) |
EP (1) | EP1971402A4 (es) |
JP (1) | JP2009523721A (es) |
KR (1) | KR20080091106A (es) |
CN (1) | CN101166559B (es) |
AU (1) | AU2006335367B2 (es) |
BR (1) | BRPI0621181A8 (es) |
CA (1) | CA2632415A1 (es) |
CU (1) | CU23810A3 (es) |
HK (1) | HK1112863A1 (es) |
IL (1) | IL192746A0 (es) |
MY (1) | MY150706A (es) |
NZ (1) | NZ570379A (es) |
RU (1) | RU2462264C2 (es) |
TW (1) | TWI503125B (es) |
WO (1) | WO2007081287A1 (es) |
ZA (1) | ZA200806339B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2605583C (en) * | 2005-06-08 | 2013-05-28 | Newbiomed Pika Pte Ltd | Polyinosinic acid-polycytidylic acid-based adjuvant |
US20070166239A1 (en) * | 2006-01-13 | 2007-07-19 | Haixiang Lin | Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
US20070166800A1 (en) * | 2006-01-13 | 2007-07-19 | Haixiang Lin | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant |
CA2715293A1 (en) * | 2008-02-15 | 2009-08-20 | Hemispherx Biopharma, Inc. | Selective agonist of toll-like receptor 3 |
US9303068B2 (en) | 2012-11-30 | 2016-04-05 | The Regents Of The University Of California | D-amino acid derivative-modified peptidoglycan and methods of use thereof |
EP2996719B1 (en) * | 2013-05-14 | 2019-06-26 | Zoetis Services LLC | Novel vaccine compositions comprising immunostimulatory oligonucleotides |
US9580758B2 (en) | 2013-11-12 | 2017-02-28 | Luc Montagnier | System and method for the detection and treatment of infection by a microbial agent associated with HIV infection |
CN106163554B (zh) * | 2014-12-23 | 2021-09-07 | 依生生物制药(新加坡)私人有限公司 | 一种包含pika佐剂的狂犬病组合物 |
WO2016176380A1 (en) * | 2015-04-28 | 2016-11-03 | The Procter & Gamble Company | Compositions comprising whole, non-viable micrococcus for improving skin health |
CN105396130A (zh) * | 2015-11-10 | 2016-03-16 | 林海祥 | 皮氨钙佐剂及含有皮氨钙佐剂的疫苗 |
CH713097B1 (de) * | 2015-11-17 | 2019-07-15 | Bioncotech Therapeutics S L | Neue pharmazeutische Zusammensetzung umfassend Partikel umfassend einen Komplex eines doppelsträngigen Polyribonukleotids und eines Polyalkylenimins. |
CN106075431A (zh) * | 2016-03-23 | 2016-11-09 | 林海祥 | 皮氨钙联合佐剂及含有皮氨钙联合佐剂的疫苗 |
CN114632091A (zh) * | 2016-04-01 | 2022-06-17 | 依生生物制药(新加坡)私人有限公司 | 用于治疗癌症的含有聚核苷酸的药物组合物 |
CN106075432A (zh) * | 2016-04-27 | 2016-11-09 | 林海祥 | 皮卡钙联合佐剂及含有皮卡钙联合佐剂的疫苗 |
CN109125264B (zh) | 2017-06-19 | 2020-10-30 | 林海祥 | 一种抗感染抗肿瘤的粘膜免疫制剂 |
AU2018313636A1 (en) * | 2017-08-10 | 2020-03-26 | Yisheng Biopharma (Singapore) Pte Ltd | A composition for treating and/or preventing hepatitis B virus infection and the use thereof |
CN109078180B (zh) * | 2018-06-29 | 2019-05-31 | 信福(北京)医药科技有限公司 | 用于增强免疫响应的复合物 |
KR20210025096A (ko) * | 2018-06-29 | 2021-03-08 | 신푸 (베이징) 메디칼 테크놀로지 코포레이션 리미티드 | 면역 반응 증강용 복합체의 제조 방법 |
CN109663126A (zh) * | 2019-03-01 | 2019-04-23 | 龙阔(苏州)生物工程有限公司 | 一种疫苗佐剂及其应用及猪繁殖与呼吸综合征疫苗 |
KR20230013133A (ko) * | 2020-05-29 | 2023-01-26 | 베이징 이셍 바이오테크놀로지 컴퍼니 엘티디. | 폴리뉴클레오타이드를 포함하는 약물조성물 및 그 covid-19 예방 또는 치료에 사용되는 용도 |
US20230201340A1 (en) * | 2020-05-29 | 2023-06-29 | Children's Medical Center Corporation | Adjuvants for severe acute respiratory syndrome-related coronavirus (sars-cov) vaccines |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3692899A (en) * | 1969-12-17 | 1972-09-19 | Us Health Education & Welfare | Inhibition of transplanted tumor growth by polyinosinic-polycytidylic acid in mice |
US3666646A (en) * | 1970-05-15 | 1972-05-30 | Merck & Co Inc | Reduction of molecular weight in polynucleotides using ultrasonic radiation |
US4124702A (en) * | 1971-07-06 | 1978-11-07 | Merck & Co., Inc. | Polynucleotides active as inducers of interferon production in living animal cells |
US3906092A (en) * | 1971-11-26 | 1975-09-16 | Merck & Co Inc | Stimulation of antibody response |
US4186194A (en) * | 1973-10-23 | 1980-01-29 | Agence Nationale De Valorisation De La Recherche (Anvar) | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
US3952097A (en) * | 1974-09-27 | 1976-04-20 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid |
US4024241A (en) * | 1974-09-27 | 1977-05-17 | The United States Of America As Represented By The Secretary Of Health, Education And Welfare | Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid |
FR2321896A1 (fr) * | 1975-08-29 | 1977-03-25 | Anvar | Agents adjuvants immunologiques actifs en solution aqueuse |
US4153684A (en) * | 1976-03-10 | 1979-05-08 | Agence Nationale De Valorisation De La Recherche (Anvar) | Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives |
US4082736A (en) * | 1976-04-26 | 1978-04-04 | Syntex (U.S.A.) Inc. | Novel immunological adjuvant compounds and methods of preparation thereof |
US4082735A (en) * | 1976-04-26 | 1978-04-04 | Syntex (U.S.A.) Inc. | Novel immunological adjuvant compounds and methods of preparation thereof |
GB1563561A (en) * | 1976-06-23 | 1980-03-26 | Daiichi Seiyaku Co | Muramyldipeptide derivatives and process for the preparation thereof |
FR2368282A1 (fr) * | 1976-10-22 | 1978-05-19 | Anvar | Adjuvant immunologique constitue par le p-amino-phenyl de n-acetyl-muramyl-l-alanyl-d-isoglutamine |
US4140761A (en) * | 1977-04-11 | 1979-02-20 | The United States Of America As Represented By The Department Of Health, Education & Welfare | Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen |
JPS55111499A (en) * | 1979-02-21 | 1980-08-28 | Takeda Chem Ind Ltd | Glucosamine derivative and its preparation |
CA1185237A (en) * | 1979-02-28 | 1985-04-09 | Yuichi Yamamura | 6-deoxyglucosamine-peptide derivatives, their production and use |
NZ194880A (en) | 1979-09-17 | 1983-07-15 | Merck & Co Inc | Interferon-inducing composition containing modified polyriboinosinic-polyribocytidylic acid |
US4349538A (en) * | 1979-12-07 | 1982-09-14 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid |
FR2476488A2 (fr) | 1980-02-25 | 1981-08-28 | Government Us America | Nouveau complexe hydrophile, resistant aux nucleases, d'acide polyriboinosinique-polyribocytidylique, son procede de preparation et son application comme inducteur d'interferon |
JPS572220A (en) | 1980-06-09 | 1982-01-07 | Toray Ind Inc | Production of interferon |
US4389395A (en) * | 1981-01-09 | 1983-06-21 | Lerner A Martin | Low molecular weight complex of polyriboinosinic-polyribocytidylic acid and method of inducing interferon |
US4400375A (en) * | 1981-11-23 | 1983-08-23 | Eli Lilly And Company | Tobramycin-double stranded RNA complex suitable for inducing interferon |
EP0190833B1 (en) * | 1985-02-07 | 1991-03-27 | Takeda Chemical Industries, Ltd. | Method for producing microcapsule |
US4857315A (en) * | 1986-09-29 | 1989-08-15 | Mount Sinai Hospital Corporation | Compositions containing golgi alpha-mannosidase II inhibitors |
JPH01186818A (ja) | 1988-01-18 | 1989-07-26 | Yamasa Shoyu Co Ltd | ポリリボイノシン酸・ポリリボシチジル酸・ポリ−l−リジン複合体製剤 |
US5230883A (en) * | 1989-05-04 | 1993-07-27 | Wisconsin Alumni Research Foundation | Method for localization and treatment of tumors using polylysine complexes |
CN1056315C (zh) * | 1993-05-31 | 2000-09-13 | 林海祥 | 聚肌胞复合物免疫佐剂及含有该佐剂的疫苗 |
EP0805678B1 (en) * | 1995-01-05 | 2003-10-29 | THE BOARD OF REGENTS acting for and on behalf of THE UNIVERSITY OF MICHIGAN | Surface-modified nanoparticles and method of making and using same |
US6096291A (en) * | 1996-12-27 | 2000-08-01 | Biovector Therapeutics, S.A. | Mucosal administration of substances to mammals |
CA2203843C (en) * | 1997-04-28 | 2013-07-23 | Her Majesty The Queen, In Right Of Canada, As Represented By The Ministe R Of National Defence | Liposome-encapsulated poly iclc |
US6514948B1 (en) * | 1999-07-02 | 2003-02-04 | The Regents Of The University Of California | Method for enhancing an immune response |
US20070219149A1 (en) | 2003-08-11 | 2007-09-20 | The Research Foundation For Microbial Diseases Of Osaka University | Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity |
JP2008506361A (ja) * | 2004-04-28 | 2008-03-06 | パラダイム・セラピューティクス・リミテッド | イオンチャネル |
CA2605583C (en) * | 2005-06-08 | 2013-05-28 | Newbiomed Pika Pte Ltd | Polyinosinic acid-polycytidylic acid-based adjuvant |
US20070166800A1 (en) * | 2006-01-13 | 2007-07-19 | Haixiang Lin | Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant |
US20070166239A1 (en) * | 2006-01-13 | 2007-07-19 | Haixiang Lin | Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
-
2006
- 2006-01-13 US US11/331,575 patent/US20070166800A1/en not_active Abandoned
- 2006-06-27 NZ NZ570379A patent/NZ570379A/en unknown
- 2006-06-27 CN CN2006800007767A patent/CN101166559B/zh active Active
- 2006-06-27 WO PCT/SG2006/000176 patent/WO2007081287A1/en active Application Filing
- 2006-06-27 RU RU2008133217/15A patent/RU2462264C2/ru active
- 2006-06-27 BR BRPI0621181A patent/BRPI0621181A8/pt not_active Application Discontinuation
- 2006-06-27 US US12/160,583 patent/US20090175902A1/en not_active Abandoned
- 2006-06-27 CA CA002632415A patent/CA2632415A1/en not_active Abandoned
- 2006-06-27 KR KR1020087015328A patent/KR20080091106A/ko not_active Application Discontinuation
- 2006-06-27 JP JP2008550270A patent/JP2009523721A/ja active Pending
- 2006-06-27 AU AU2006335367A patent/AU2006335367B2/en active Active
- 2006-06-27 EP EP06748124A patent/EP1971402A4/en not_active Ceased
-
2007
- 2007-01-11 MY MYPI20070043 patent/MY150706A/en unknown
- 2007-01-12 TW TW096101298A patent/TWI503125B/zh active
-
2008
- 2008-07-10 IL IL192746A patent/IL192746A0/en unknown
- 2008-07-14 CU CU20080135A patent/CU23810A3/es active IP Right Grant
- 2008-07-22 ZA ZA200806339A patent/ZA200806339B/xx unknown
- 2008-08-06 HK HK08108667.7A patent/HK1112863A1/xx active IP Right Revival
-
2011
- 2011-02-22 US US13/032,543 patent/US8303966B2/en active Active
-
2012
- 2012-10-01 US US13/632,903 patent/US20130115244A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA200806339B (en) | 2010-03-31 |
US8303966B2 (en) | 2012-11-06 |
AU2006335367B2 (en) | 2012-08-30 |
CA2632415A1 (en) | 2007-07-19 |
CN101166559A (zh) | 2008-04-23 |
WO2007081287A1 (en) | 2007-07-19 |
RU2462264C2 (ru) | 2012-09-27 |
EP1971402A4 (en) | 2010-07-14 |
CN101166559B (zh) | 2012-08-22 |
KR20080091106A (ko) | 2008-10-09 |
TWI503125B (zh) | 2015-10-11 |
BRPI0621181A2 (pt) | 2011-11-22 |
RU2008133217A (ru) | 2010-02-20 |
IL192746A0 (en) | 2009-02-11 |
TW200800258A (en) | 2008-01-01 |
AU2006335367A1 (en) | 2007-07-19 |
BRPI0621181A8 (pt) | 2017-09-12 |
MY150706A (en) | 2014-02-28 |
WO2007081287A9 (en) | 2007-12-21 |
US20070166800A1 (en) | 2007-07-19 |
US20130115244A1 (en) | 2013-05-09 |
HK1112863A1 (en) | 2008-09-19 |
EP1971402A1 (en) | 2008-09-24 |
JP2009523721A (ja) | 2009-06-25 |
US20110212123A1 (en) | 2011-09-01 |
NZ570379A (en) | 2012-07-27 |
US20090175902A1 (en) | 2009-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU23810A3 (es) | Sustancias inmunogénicas que comprenden un adyuvante a base de ácido poliinosínico-ácido policitidílico | |
CU23819A3 (es) | Sustancias inmunogénicas mucosales que comprenden un adyuvante a base de ácido poliinosínico-ácido policitidílico | |
IL187616A (en) | Use of an adjuvant compound containing polyinosinic acid – polycytidylic acid, antibiotics, and positive ion as an immunosuppressant | |
CY1120347T1 (el) | Εμβολιο ιου ερπητα ζωστηρα | |
WO2010005735A3 (en) | Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment | |
CY1122911T1 (el) | ΑΝΟΣΟΘΕΡΑΠΕΙΑ ΜΕ ΤΗ ΧΡΗΣΗ ΚΥΤΤΑΡΟΥ ΤΟ ΟΠΟΙΟ ΕΧΕΙ ΤΗΝ ΙΚΑΝΟΤΗΤΑ ΣΥΝΕΚΦΡΑΣΗΣ ΑΝΤΙΓΟΝΟΥ ΣΤΟΧΟΥ ΚΑΙ CD1d ΚΑΙ ΕΙΝΑΙ ΔΙΕΓΕΡΜΕΝΟ ΜΕ ΣΥΝΔΕΤΗ CD1d | |
CL2011000914A1 (es) | Vacuna combinada estable completamente liquida que comprende antigenos difterico, tetanico, pertusico acelular, de haemophilus influenzae, y de virus de poliomielitis en donde el antigeno se haemophilus influenzae no esta sustancialmente absorbido sobre ningun adyuvante; y proceso de fabricacion. | |
UY30302A1 (es) | Formulaciones de pepticuerpos terapeuticos liofilizados | |
CR10101A (es) | Nueva composición | |
AR061246A1 (es) | Anticuerpos anti- dill4 y metodos que los usan | |
GB201009273D0 (en) | Novel vaccine | |
CO6331297A2 (es) | Composiciones adyuvantes novedosas | |
BRPI0715396B8 (pt) | método de produção de uma composição para vacina | |
GT200800276A (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
ECSP099410A (es) | Adsorbente de fosfato a base de hierro (iii)-carbohidrato | |
CU23759A3 (es) | Composiciones inmunogénicas | |
CL2011003033A1 (es) | Uso de un lipopolisacarido de ochrobactrum intermedium lmg3306 o de una composición que lo comprende para el tratamiento y/o prevencion de sepsis o enfermedades infecciosas; procedimiento para la preparacion del lipopolisacárido; y composicion que comprende el lipopolisacarido. | |
BRPI0821240B8 (pt) | formas mutantes de estreptolisina o | |
AR059851A1 (es) | Anticuerpos de la egfl7 y metodos de uso | |
GB2444676A (en) | Adjuvanted vaccine | |
CO6362049A2 (es) | Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo | |
EA201200538A1 (ru) | Арабиногалактан для повышения приобретенного иммунного ответа | |
WO2009057763A1 (ja) | 新規アジュバント | |
DK1401492T3 (da) | LTB4 som vaccineadjuvans | |
CU23720A3 (es) | Adyuvante basado en ácido poliinosínico-ácido policitidílico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant of patent |